http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2241618-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df874e3cf88adba3792dc9d5b5776180 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-46 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate | 2009-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2241618-A1 |
| titleOfInvention | Prostate cancer cell lines and their use in screening method |
| abstract | The present invention relates to a prostate cancer cell line CNCM deposit number I-4126, the use thereof for preparing resistant prostate cancer cell lines, the resistant prostate cancer cell lines, and the use of these prostate cancer cell lines for screening compounds of interest. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111019902-A |
| priorityDate | 2009-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1108.